ID   2C3 [Mouse hybridoma against human VEGFA]
AC   CVCL_DE32
DR   ATCC; CRL-13018
DR   Wikidata; Q54584422
RX   Patent=US6524583;
RX   PubMed=9581838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1595.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
CC   Discontinued: ATCC; CRL-13018; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 8
//
RX   Patent=US6524583;
RA   Thorpe P.E., Brekken R.A.;
RT   "Antibody methods for selectively inhibiting VEGF.";
RL   Patent number US6524583, 25-Feb-2003.
//
RX   PubMed=9581838;
RA   Brekken R.A., Huang X., King S.W., Thorpe P.E.;
RT   "Vascular endothelial growth factor as a marker of tumor
RT   endothelium.";
RL   Cancer Res. 58:1952-1959(1998).
//